Phase 1b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of SPI-1005 in Meniere's Disease
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 27 Jun 2017
At a glance
- Drugs Ebselen (Primary)
- Indications Meniere's disease
- Focus Adverse reactions
- Sponsors Sound Pharmaceuticals
- 27 Jun 2017 According to a Sound Pharmaceuticals media release, status changed from recruiting to active, no longer recruiting.
- 11 Dec 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 17 Nov 2015 New trial record